UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14C INFORMATION
Information
Statement Pursuant to Section 14(c)
of
the Securities Exchange Act of 1934
Check the appropriate box:
| ☒ | Preliminary Information Statement |
| ☐ | Confidential, for use of the
Commission only (as permitted by Rule 14c-5(d)(2)) |
| ☐ | Definitive Information Statement |
MITESCO, INC.
(Name of Registrant
As Specified In Its Charter)
Payment of Filing Fee (Check the appropriate
box):
| ☐ | Fee paid previously with preliminary
materials. |
| ☐ | Fee
computed on table in exhibit required by Item 25(b) of Schedule 14A (17 CFR 240.14a-101) per Item 1 of this Schedule and Exchange Act
Rules 14c-5(g) and 0-11. |
MITESCO, INC.
505 Beachland
Blvd., Suite 1377
Vero Beach, Florida 32963
NOTICE OF ACTION
BY WRITTEN CONSENT OF HOLDERS OF A MAJORITY OF THE OUTSTANDING VOTING STOCK OF MITESCO, INC.
This notice and accompanying Information
Statement are furnished to the holders of record of common stock, par value $0.001 per share (“Common Stock”), of
MITESCO, INC., a Nevada corporation (“we,” “us,” “our” or the “Company”), pursuant
to Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulation 14C and Schedule
14C thereunder, in connection with the approval of the action described below.
On November 5, 2026, the
Board of Directors (the “Board”) approved via unanimous written consent an amendment to the Company’s Articles of Incorporation
to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000) to one billion
(1,000,000,000), with a par value of $0.001 per share (the “Authorized Stock Increase”), and on November 18, 2026, modified that consent to increase the authorized common stock
to 20 billion (20,000,000,000). We recommended the shareholders of the Series X Preferred shares approve the Authorized Stock Increase. On November 18, 2026, shareholders holding 50.95% of Company’s voting stock, voting on as-converted
basis (“Consenting Shareholders”) took this action by written consent to approve the Authorized Stock Increase.
Shareholders of record at the close of
business on November 18, 2026, are entitled to notice of this shareholder action by written consent. Because this action has been
approved by the holders of the required majority of the voting power of our voting stock, no proxies were or are being solicited.
Attached hereto for
your review is an Information Statement relating to the Authorized Stock Increase. Please read this Information Statement carefully.
It describes the essential terms of the actions to be taken. Additional information about the Company is contained in its reports filed
with or furnished to the Securities and Exchange Commission (the “SEC”). The SEC maintains a website that contains reports,
proxy and information statements and other information regarding public companies that file reports with the SEC. Copies of these reports
may be obtained on the SEC’s website at www.sec.gov.
WE ARE NOT ASKING YOU
FOR A CONSENT OR PROXY AND YOU ARE REQUESTED NOT TO SEND US A CONSENT OR PROXY. THIS IS NOT A NOTICE OF A MEETING OF SHAREHOLDERS AND
NO SHAREHOLDERS’ MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN. THIS INFORMATION STATEMENT IS BEING FURNISHED TO
YOU SOLELY FOR THE PURPOSE OF INFORMING YOU OF THE MATTERS DESCRIBED HEREIN.
| | By Order of the Board of Directors, |
| | |
November 20, 2026
| | /s/ Mack Leath |
| | Mack Leath, Chairman and CEO |
| | |
| | /s/ Brian Valania |
| | Brian Valania, CEO |
| | |
| | /s/ Frank Panunto |
| | Frank Panunto, Director |
MITESCO, INC.
505 Beachland
Blvd., Suite 1377
Vero Beach, Florida 32963
INFORMATION STATEMENT
WE ARE NOT ASKING YOU
FOR A CONSENT OR PROXY AND YOU
ARE REQUESTED NOT TO SEND US A CONSENT OR PROXY.
INTRODUCTION
Pursuant to Section
14(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulation 14C promulgated thereunder,
the above notice and this information statement (the “Information Statement”) is being sent or given on or about November 18,
2026, to the shareholders of record, as of November 18, 2026 (the “Record Date”), of MITESCO, INC., a Nevada corporation (hereinafter
referred to as “we,” “us,” “our,” or the “Company”). This Information Statement is being
circulated to advise shareholders of certain actions already approved and taken without a meeting by written consent of shareholders
who hold a majority of the voting power of our voting stock.
On November 18,
2026, our Board approved via unanimous written consent and recommended our shareholders to approve, and on November 18, 2026, shareholders
holding an aggregate of 52,422,057 votes of the Company’s voting stock carrying a vote equal to 50.95% of all shares entitled to vote
approved and consented in writing to the following action. These votes include votes cast by five (5), of our shareholders, who holds
certain shares of common stock and 100% of Series X preferred stock. Pursuant to the rights set forth in the Series X certificate
of designation, Series X preferred stockholders are entitled to vote together as a single class with our common stockholders on as-converted
basis on all matters submitted to vote at a ratio of 400 votes per share of Series X preferred stock.
| ● | The approval of an amendment to the Company’s Articles
of Incorporation to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000)
to twenty billion (20,000,000,000), with a par value of $0.001 per share. |
Such approval and consent
constitute the approval and consent of a majority of the total number of shares of issued and outstanding voting stock and are sufficient
under the Nevada Revised Statutes (“NRS”) and our articles of incorporation and bylaws to approve the action. Accordingly,
the action will not be submitted to the other shareholders of the Company for a vote, and this Information Statement is being furnished
to shareholders to provide them with certain information concerning the action in accordance with the requirements of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and the regulations promulgated thereunder, including Regulation 14C.
This notice is also deemed to satisfy the notice requirement prescribed under the NRS.
ACTIONS BY BOARD OF
DIRECTORS AND CONSENTING SHAREHOLDER
On November 5, 2026,
the Board unanimously approved the Authorized Stock Increase. Subsequent to the Board’s approval, the Consenting Shareholders approved
the Authorized Stock Increase. The Consenting Shareholders and its approximate ownership percentage of 50.95% our voting stock as of
November 18, 2026, were as follows:
Common shares outstanding at
11-18-2026 (2) |
|
66,481,654 |
|
|
Preferred X shares outstanding at
11-18-2026 |
|
|
91,103 |
|
|
Votes from Preferred X super voting (3) |
|
|
36,441,200 |
|
|
|
|
|
Total voting shares including common and super votes from Preferred X |
|
|
102,922,854 |
|
| Name |
|
Amount and Nature of Beneficial Ownership of Common Stock |
|
|
Percentage of
Common Stock Beneficially Owned |
|
|
Number of
Shares of Series X Preferred Stock |
|
|
Percentage of Series X Preferred Stock |
|
|
Number of
votes at 400 per share |
|
|
Add common shares
held at
11/5/2026 |
|
|
Total Votes |
|
|
% of the Total Votes |
|
| MACK LEATH (1) |
|
|
3,741,266 |
|
|
|
5.63 |
% |
|
|
12,000 |
|
|
|
13.17 |
% |
|
|
4,800,000 |
|
|
|
3,741,266 |
|
|
|
8,541,266 |
|
|
|
8.30 |
% |
| FRANK PANUNTO (1) |
|
|
3,000,000 |
|
|
|
4.51 |
% |
|
|
12,000 |
|
|
|
13.17 |
% |
|
|
4,800,000 |
|
|
|
3,000,000 |
|
|
|
7,800,000 |
|
|
|
7.58 |
% |
| BRIAN VALANIA (1) |
|
|
3,504,412 |
|
|
|
5.27 |
% |
|
|
12,000 |
|
|
|
13.17 |
% |
|
|
4,800,000 |
|
|
|
3,504,412 |
|
|
|
8,304,412 |
|
|
|
8.07 |
% |
| Current Executive Officers and Directors as a group (3 Persons) |
|
|
10,245,678 |
|
|
|
15.41 |
% |
|
|
36,000 |
|
|
|
39.52 |
% |
|
|
14,400,000 |
|
|
|
10,245,678 |
|
|
|
24,645,678 |
|
|
|
23.95 |
% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5% or more shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JIM CLIFTON |
|
|
317,403 |
|
|
|
0.48 |
% |
|
|
2,400 |
|
|
|
2.63 |
% |
|
|
960,000 |
|
|
|
317,403 |
|
|
|
1,277,403 |
|
|
|
1.24 |
% |
| JORDAN BALENCIC (1) |
|
|
3,421,904 |
|
|
|
5.15 |
% |
|
|
7,200 |
|
|
|
7.90 |
% |
|
|
2,880,000 |
|
|
|
3,421,904 |
|
|
|
6,301,904 |
|
|
|
6.12 |
% |
| JOHN MITCHELL |
|
|
387,235 |
|
|
|
0.58 |
% |
|
|
2,400 |
|
|
|
2.63 |
% |
|
|
960,000 |
|
|
|
387,235 |
|
|
|
1,347,235 |
|
|
|
1.31 |
% |
| ANGLO IRISH MANAGEMENT, LLC (1) (4) |
|
|
4,253,275 |
|
|
|
6.40 |
% |
|
|
43,103 |
|
|
|
47.31 |
% |
|
|
17,241,200 |
|
|
|
4,253,275 |
|
|
|
21,494,475 |
|
|
|
20.88 |
% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total for this vote (4) |
|
|
|
52,442,057 |
|
|
|
50.95 |
% |
| (1) |
These individuals have voted their Common Stock and Series X Preferred shares to approve this action |
| (2) |
Calculated based on the 66,481,654 shares of Common Stock issued and outstanding as of November 18, 2026. |
| (3) | Calculated based on 91,103 shares of Series X Preferred Stock
outstanding. Each share of Series X preferred stock is entitled to 400 votes and to vote together as a single class with common
stockholders on all matters submitted to a vote. |
| (4) | Calculated based on 102,922,854 shares of issued and outstanding voting capital stock, including
66,481,654 shares of Common Stock, and 91,103 shares of Series X preferred stock calculated on an as-converted basis for the purposes
of voting on the Authorized Stock Increase. |
SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
| ● | Each person known by the Company to beneficially own more
than 5% of the Company’s outstanding Common Stock; |
| ● | Each of the named executive officers (as defined in Item 402
of Regulation S-K); |
| ● | Each of our directors, and |
| ● | All of the Company’s executive officers and directors
as a group. |
The following table
sets forth certain information regarding the beneficial ownership of our issued and outstanding Common Stock and preferred stock as of
November 18, 2026, by the following persons:
Common shares outstanding at
11-18-2026 (1) | |
| 66,481,654 | | |
| Preferred X shares outstanding at
11-18-2026 | | |
| 91,103 | | |
| Votes from Preferred X super voting: | | |
| 36,441,200 | | |
| | | |
| Total votng shares including common and super votes from Preferred X | | |
| 102,922,854 | |
| Name | |
| Amount and Nature of Beneficial Ownership of Common Stock | | |
| Percentage of Common Stock Beneficially Owned | | |
| Number of Shares of Series X Preferred Stock | | |
| Percentage of Series X Preferred Stock | | |
| Number of votes at 400 per share | | |
| Add common shares held at 11/5/2026 | | |
| Total Votes | | |
| % of the Total Votes | |
| MACK LEATH (1) | |
| 3,741,266 | | |
| 5.63 | % | |
| 12,000 | | |
| 13.17 | % | |
| 4,800,000 | | |
| 3,741,266 | | |
| 8,541,266 | | |
| 8.30 | % |
| FRANK PANUNTO (1) | |
| 3,000,000 | | |
| 4.51 | % | |
| 12,000 | | |
| 13.17 | % | |
| 4,800,000 | | |
| 3,000,000 | | |
| 7,800,000 | | |
| 7.58 | % |
| BRIAN VALANIA (1) | |
| 3,504,412 | | |
| 5.27 | % | |
| 12,000 | | |
| 13.17 | % | |
| 4,800,000 | | |
| 3,504,412 | | |
| 8,304,412 | | |
| 8.07 | % |
| Current Executive Officers and Directors as a group (3 Persons) | |
| 10,245,678 | | |
| 15.41 | % | |
| 36,000 | | |
| 39.52 | % | |
| 14,400,000 | | |
| 10,245,678 | | |
| 24,645,678 | | |
| 23.95 | % |
| 5% or more shareholders | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| JORDAN BALENCIC (1) | |
| 3,421,904 | | |
| 5.15 | % | |
| 7,200 | | |
| 7.90 | % | |
| 2,880,000 | | |
| 3,421,904 | | |
| 6,301,904 | | |
| 6.12 | % |
| ANGLO IRISH MANAGEMENT, LLC (1) (4) | |
| 4,253,275 | | |
| 6.40 | % | |
| 43,103 | | |
| 47.31 | % | |
| 17,241,200 | | |
| 4,253,275 | | |
| 21,494,475 | | |
| 20.88 | % |
| Current Executive Officers and Directors & 5% holders | |
| 17,920,857 | | |
| 27 | % | |
| 86,303 | | |
| 95 | % | |
| 34,521,200 | | |
| 17,920,857 | | |
| 52,442,057 | | |
| 50.95 | % |
| (1) | Based upon 66,481,654 shares of Common Stock and 91,103 shares
of Series X Preferred Stock. Each Series X Preferred Stock is entitled to 400 votes per share or an aggregate of 102,922,854
votes. |
| (2) | The address for each Director is 505 Beachland Blvd., Suite
1-377, Vero Beach, FL 32963 |
Beneficial ownership is
determined in accordance with the rules and regulations of the SEC. The number of shares and the percentage beneficially owned by each
individual listed below include shares that are subject to options held by that individual that are immediately exercisable or exercisable
within 60 days from November 18, 2026, and the number of shares and the percentage beneficially owned by all officers and directors
as a group includes shares subject to options held by all officers and directors as a group that are immediately exercisable or exercisable
within 60 days from November 18, 2026.
The above table
assumes based on our stock records, that there are 66,481,654 shares of Common Stock and 91,103 shares of Series X Preferred
Stock issued and outstanding as of November 18, 2026:
Security Ownership of Management and Beneficial Owners
Changes in Control
We are unaware of any contract of other arrangement the
operation of which may at a subsequent date result in a change of control of our Company.
ACTION ONE –
INCREASE IN AUTHORIZED COMMON STOCK
General
On November 18,
2026, the Board, and on November 18, 2026, the Consenting Shareholders approved the Authorized Stock Increase, which increases the
total number of common stock the Company is authorized to issue from five hundred million (500,000,000) to twenty billion (20,000,000,000),
with a par value of $0.001 per share.
Purpose of the Authorized Common Stock Increase
On November 18, 2026, the Board, and on November 18, 2026, the Consenting Shareholders approved the Authorized Stock Increase,
which increases the total number of common stock shares which the Company is authorized to issue from five hundred million (500,000,000)
to twenty billion (20,000,000,000), with a par value of $0.001 per share.
As a result of this action the Company is authorized
to issue up to 20,000,000,000 shares of Common Stock. Our issued and outstanding share count was 66,481,654 as of November 18, 2026. As such, we will be
authorized to issue approximately 19,933,518,346 shares to new stockholders. As of November 18, 2026, we have 906,396,294 shares reserved for issuance for options,
warrants and other convertible instruments as required by the terms of our lending, and other agreements. Our Board and the Consenting Shareholders believe that an additional 19,500,000,000
increase in our authorized stock will provide the Company with additional flexibility to use its capital stock for business and financial
purposes in the future. These purposes may include raising capital; establishing strategic relationships with other companies; expanding
our business through the acquisition of other businesses or products; providing additional equity incentives to employees, officers or
directors; and other purposes. Our Board believes that these additional shares will provide us with needed flexibility to issue shares
in the future without potential expense and delay incident to obtaining Shareholder approval for a particular issuance.
We are not in any formal
discussions with potential acquisition targets at the current time, and no formal agreements exist which will require the issuance of
additional Common Stock as of the date of this Information Statement. However, management will need the flexibility to issue Common Stock,
warrants, or preferred stock convertible into Common Stock to funders that will provide the capital required to close any future growth
opportunities, as well as provide other working capital to the Company. No such definitive agreement for growth opportunities or equity
funding exist at this time.
Potential Effects of Proposed Authorized Common Stock
Increase
The Authorized Stock
Increase will affect all holders of our Common Stock uniformly. The Authorized Stock Increase is not intended to, and will not, affect
any shareholder’s percentage ownership interest in our Company, except for effects incidental to increasing the number of shares
of our Common Stock outstanding, such as dilution of the earnings per share and voting rights of current holders of Common Stock, to
the extent the additional Common Stock is ultimately issued.
The Authorized Stock
Increase will not change the terms of our Common Stock. After the Authorized Stock Increase, the shares of our Common Stock will have
the same voting rights and rights to dividends and distributions and will be identical in all other respects to our Common Stock now
authorized. Our Common Stock will remain fully paid and non-assessable.
Vote Required
Pursuant to the NRS,
the approval of the Authorized Stock Increase requires a majority of the Company’s outstanding voting stock. As discussed above,
holders of a majority of votes of the Company’s voting stock, voting together as a class, have consented to the Authorized Stock
Increase.
INTEREST OF CERTAIN PERSONS IN OR IN OPPOSITION TO
MATTERS TO BE ACTED UPON
There is no substantial
interest, direct or indirect, by security holdings or otherwise, of any person who has been director or officer of the Company at any
time since the beginning of the last fiscal year in the Authorized Stock Increase.
PROPOSALS BY SECURITY HOLDERS
The Board knows of
no other matters or proposals other than the actions described in this Information Statement that have been approved or considered by
the holders of a majority of the shares of the Company’s stock.
DISSENTERS’
RIGHTS
There are no rights of appraisal
or similar rights of dissenters with respect to any matter described in this Information Statement.
RECORD DATE AND VOTING SECURITIES
Only shareholders of
record at the close of business on the Record Date are entitled to notice of the information disclosed in this Information Statement.
As of the Record Date, our authorized common shares consist of five hundred million (500,000,000) shares of Common Stock with a par value
of $0.001 per share. As of the Record Date, there were 60,153,708 shares of Common Stock and 91,108 shares of Series X preferred
stock issued and outstanding. Each share of Common Stock is entitled to one vote per share. Each share of Preferred Stock is entitled
to 400 votes per share and can vote alongside common stockholders as a single class.
EXPENSES
The costs of preparing, printing and mailing this Information
Statement will be borne by the Company.
THIS IS NOT A NOTICE
OF A MEETING OF SHAREHOLDERS AND NO SHAREHOLDERS’ MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN. THIS INFORMATION
STATEMENT IS BEING FURNISHED TO YOU SOLELY FOR THE PURPOSE OF INFORMING YOU OF THE MATTERS DESCRIBED HEREIN.
SHAREHOLDERS’
RIGHTS
The elimination of
the need for a special meeting of the shareholders to approve the actions described in this Information Statement is authorized by the
Nevada Revised Statutes (“NRS”). The NRS provides that any action required or permitted to be taken at a meeting of shareholders
of a corporation may be taken without a meeting, if a written consent thereto is signed by holders of outstanding shares having not less
than the minimum number of votes that would be necessary to authorize or take that action at a meeting at which all shares entitled to
vote thereon were present and voted. In order to eliminate the costs and management time involved in holding a special meeting and in
order to effect the action disclosed herein as quickly as possible in order to accomplish the purposes of our Company, we chose to obtain
the written consent of a majority of our voting power to approve the action described in this Information Statement.
ADDITIONAL INFORMATION
We are subject to the
disclosure requirements of the Exchange Act, and in accordance therewith, file reports, information statements and other information,
including annual and quarterly reports on Form 10-K and 10-Q, respectively, with the SEC. The SEC maintains a website (http://www.sec.gov)
that contains reports, information statements and other information regarding issuers that file electronically with the SEC through the
EDGAR system, where reports and other information filed or furnished by us can be inspected. You may also request a copy of documents
filed with or furnished to the SEC by us, at no cost, by writing to MITESCO, INC., 505 Beachland Blvd., Suite 1377, Vero Beach, Florida
32963, Attn: Mack Leath, Chairman and CEO, or by telephoning the Company at 844-383-8689.
Our principal executive
office is located at 505 Beachland Blvd., Suite 1377, Vero Beach, Florida 32963. Our corporate website is https://www.mitesco.com/ and
our phone number is 844-383-8689.
NOTICE OF INTERNET
AVAILABILITY OF INFORMATION STATEMENT
Under the Securities and
Exchange Commission rules, you are receiving notice that this Information Statement is also available on the Internet. You may access
the Information Statement online at https://www.sec.gov/edgar/browse/?CIK=802257&owner=exclude. When you go online, you can
also help the environment by consenting to receive electronic delivery of future materials.
DELIVERY OF DOCUMENTS TO SECURITY HOLDERS SHARING
AN ADDRESS
If hard copies of the
materials are requested, we will send only one Information Statement and other corporate mailings to shareholders who share a single
address unless we received contrary instructions from any shareholder at that address. This practice, known as “householding,”
is designed to reduce our printing and postage costs. However, the Company will deliver promptly upon written or oral request a separate
copy of the Information Statement to a shareholder at a shared address to which a single copy of the Information Statement was delivered.
You may make such a written or oral request by (a) sending a written notification stating (i) your name, (ii) your shared address and
(iii) the address to which the Company should direct the additional copy of the Information Statement, to MITESCO, INC., 505 Beachland
Blvd., Suite 1377, Vero Beach, Florida 32963, Attn: Mack Leath, Chairman and CEO, or by telephoning the Company at 844-383-8689.
If multiple shareholders
sharing an address have received one copy of this Information Statement or any other corporate mailing and would prefer the Company to
mail each shareholder a separate copy of future mailings, you may mail notification to, or call the Company at, its principal executive
offices. Additionally, if current shareholders with a shared address received multiple copies of this Information Statement or other
corporate mailings and would prefer the Company to mail one copy of future mailings to shareholders at the shared address, notification
of such request may also be made by mail or telephone to the Company’s principal executive offices.
NO ADDITIONAL ACTION
IS REQUIRED BY OUR SHAREHOLDERS IN CONNECTION WITH THESE ACTIONS. HOWEVER, SECTION 14C OF THE EXCHANGE ACT REQUIRES THE MAILING TO
OUR SHAREHOLDERS OF THE INFORMATION SET FORTH IN THIS INFORMATION STATEMENT AT LEAST 20 DAYS PRIOR TO THE EARLIEST DATE ON WHICH THE
CORPORATE ACTION MAY BE TAKEN.
| | MITESCO, INC. |
| | |
| November 20, 2026 | /s/ Mack Leath |
| | Mack Leath |
| | Chairman |